Physician profile
Fred C Redfern
NPI 1104893031
$3,518.56
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,092 · 2020: $967 · 2021: $1,460.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Goode Surgical INC | $2,065.81 | 2019-2021 | |
| Stryker Corporation | $696.64 | 2019-2021 | |
| Avanos Medical | $453.97 | 2019 | |
| Curasan, INC. | $96.26 | 2019 | |
| Integra Lifesciences Corporation | $89.34 | 2020 | |
| Conformis, INC. | $77.38 | 2021 | |
| Depuy Synthes Sales INC. | $23.09 | 2020 | |
| Amniox Medical, INC. | $16.07 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Redfern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.